Dirk J. Grünhagen - Concepedia

Author

Dirk J. Grünhagen

Also Known As

A Gronchi, D Grnhagen, D Grunhagen, D Grünhagen, D J Grunhagen, D J Grünhagen, D. Grunhagen, D. Grünhagen, D. J. Grunhagen, D. J. Grünhagen

513

Publications

9.3K

Citations

H-Index

104

Concepts

All Affiliations

Erasmus MC Cancer Institute The Netherlands Cancer Institute Radboud University Nijmegen Erasmus MC University Medical Center Groningen

About

Dirk J. Grünhagen is an author at Erasmus MC Cancer Institute specializing in medicine, oncology, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	55	2.9K
2	Health Sciences	10	10	281
3	Engineering	2	2	59
4	Cell Biology	1	1	626
5	Computer Science	1	1	19

Dirk J. Grünhagen

167

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder, Cancer Cell Cancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint InhibitorT Cell Immunity	2020	626
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial Irene L. M. Reijers, Alexander M. Menzies, Alexander C. J. van Akkooi, Nature Medicine Surgical OncologyOncologyPrado TrialMelanomaClinical Trials	2022	322
International consensus guidelines for scoring the histopathological growth patterns of liver metastasis Pieter‐Jan van Dam, Eric P. van der Stok, Laure-Anne Teuwen, British Journal of Cancer	2017	223
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld, The Lancet Oncology Surgical OncologyHepatologyMedicineHepatobiliary TumorColorectal Cancer	2023	153
Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor‐α and melphalan for limb‐threatening soft tissue sarcoma Dirk J. Grünhagen, Johannes H. W. de Wilt, Wilfried J. Graveland, Cancer	2006	137
Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma Alexander C. J. van Akkooi, Marna G. Bouwhuis, A.N. van Geel, European Journal of Surgical Oncology Surgical OncologyMedicineSurgical PathologyMelanomaSurgery	2006	133
Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases Boris Galjart, Pieter M. H. Nierop, Eric P. van der Stok, Angiogenesis	2019	128
One Hundred Consecutive Isolated Limb Perfusions With TNF-α and Melphalan in Melanoma Patients With Multiple In-Transit Metastases Dirk J. Grünhagen, Flávia Brunstein, Wilfried J. Graveland, Annals of Surgery	2004	125
Multicenter Observational Study of Adhesion Formation After Open-and Laparoscopic Surgery for Colorectal Cancer Martijn W.J. Stommel, Richard P. G. ten Broek, Chema Strik, Annals of Surgery	2017	125
Prognostic Value of CTNNB1 Gene Mutation in Primary Sporadic Aggressive Fibromatosis Danique L. M. van Broekhoven, Cornelis Verhoef, Dirk J. Grünhagen, Annals of Surgical Oncology Ctnnb1 Gene MutationFibrosisPrognostic ValuePathologyPulmonary Fibrosis	2014	122

Page 1